IL128546A0 - Cycloalkyl inhibitors of protein farnesyltransferase - Google Patents

Cycloalkyl inhibitors of protein farnesyltransferase

Info

Publication number
IL128546A0
IL128546A0 IL12854697A IL12854697A IL128546A0 IL 128546 A0 IL128546 A0 IL 128546A0 IL 12854697 A IL12854697 A IL 12854697A IL 12854697 A IL12854697 A IL 12854697A IL 128546 A0 IL128546 A0 IL 128546A0
Authority
IL
Israel
Prior art keywords
protein farnesyltransferase
inhibitors
cycloalkyl
cycloalkyl inhibitors
protein
Prior art date
Application number
IL12854697A
Other languages
English (en)
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of IL128546A0 publication Critical patent/IL128546A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • C07K5/06147Dipeptides with the first amino acid being heterocyclic and His-amino acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL12854697A 1996-12-17 1997-12-16 Cycloalkyl inhibitors of protein farnesyltransferase IL128546A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3366196P 1996-12-17 1996-12-17
US5683197P 1997-08-22 1997-08-22
PCT/US1997/023280 WO1998027109A1 (en) 1996-12-17 1997-12-16 Cycloalkyl inhibitors of protein farnesyltransferase

Publications (1)

Publication Number Publication Date
IL128546A0 true IL128546A0 (en) 2000-01-31

Family

ID=26709973

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12854697A IL128546A0 (en) 1996-12-17 1997-12-16 Cycloalkyl inhibitors of protein farnesyltransferase

Country Status (21)

Country Link
US (1) US6281194B1 (de)
EP (1) EP0951471B1 (de)
JP (1) JP2001506265A (de)
KR (1) KR20000057601A (de)
AT (1) ATE261987T1 (de)
AU (1) AU721786C (de)
BR (1) BR9713744A (de)
CA (1) CA2264207A1 (de)
CO (1) CO4920227A1 (de)
DE (1) DE69728165T2 (de)
DK (1) DK0951471T3 (de)
ES (1) ES2216189T3 (de)
HR (1) HRP970693B1 (de)
ID (1) ID19142A (de)
IL (1) IL128546A0 (de)
NO (1) NO992933L (de)
NZ (1) NZ334702A (de)
PE (1) PE46999A1 (de)
PT (1) PT951471E (de)
TW (1) TW552259B (de)
WO (1) WO1998027109A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0951471B1 (de) 1996-12-17 2004-03-17 Warner-Lambert Company Llc Cycloalkyl inhibitoren der protein-farnesyltransferase
EP1076663B1 (de) 1998-04-27 2004-02-18 Warner-Lambert Company LLC Glycinamidederivate mit funktionalisierter alkyl- und alkenylseitenkette als inhibitoren der farnesyltransferase
US6455734B1 (en) * 2000-08-09 2002-09-24 Magnesium Diagnostics, Inc. Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
AU2007229363B2 (en) * 2001-08-24 2009-06-04 University Of South Florida Piperazinone Compounds as Anti-Tumor and Anti-Cancer Agents and the Methods of Treatment
EP1427418B1 (de) * 2001-08-24 2009-11-11 Yale University Piperazinon-verbindungen als antitumorale und krebsbekämpfende mittel
US20070275956A1 (en) * 2003-10-14 2007-11-29 Lohray Braj B Novel Heterocyclic Compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ275691A (en) * 1993-11-05 1998-03-25 Warner Lambert Co Di and tripeptides and compositions thereof which inhibit farnesyl transferase
US5571792A (en) 1994-06-30 1996-11-05 Warner-Lambert Company Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase
EP0951471B1 (de) 1996-12-17 2004-03-17 Warner-Lambert Company Llc Cycloalkyl inhibitoren der protein-farnesyltransferase

Also Published As

Publication number Publication date
KR20000057601A (ko) 2000-09-25
ID19142A (id) 1998-06-18
EP0951471A1 (de) 1999-10-27
AU5899098A (en) 1998-07-15
DE69728165D1 (de) 2004-04-22
DE69728165T2 (de) 2005-01-20
DK0951471T3 (da) 2004-07-19
HRP970693B1 (en) 2002-06-30
TW552259B (en) 2003-09-11
NO992933D0 (no) 1999-06-16
AU721786B2 (en) 2000-07-13
CO4920227A1 (es) 2000-05-29
BR9713744A (pt) 2000-03-21
WO1998027109A1 (en) 1998-06-25
US6281194B1 (en) 2001-08-28
PT951471E (pt) 2004-08-31
HRP970693A2 (en) 1998-10-31
JP2001506265A (ja) 2001-05-15
PE46999A1 (es) 1999-05-20
AU721786C (en) 2001-08-02
NO992933L (no) 1999-06-16
ATE261987T1 (de) 2004-04-15
ES2216189T3 (es) 2004-10-16
NZ334702A (en) 2000-11-24
EP0951471B1 (de) 2004-03-17
CA2264207A1 (en) 1998-06-25

Similar Documents

Publication Publication Date Title
ZA955411B (en) Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase
DE69427127D1 (de) Substituierte tetra- und pentapeptid hemmstoffe der farnesyl protein transferase
CA2315647A1 (en) Inhibition of p38 kinase activity using aryl and heteroaryl substituted heterocyclic ureas
AU7585498A (en) Inhibition of p38 kinase activity by aryl ureas
AU2003200722A1 (en) Compositions and methods for the treatment of tumor
AU5186799A (en) Peptides of il-2 and derivatives thereof and their use as therapeutic agents
EP1978031A3 (de) Tropoelastin-Derivate
WO2001079164A3 (en) N-substituted dithiocarbamates for the treatment of biological disorders
AU2002350623A1 (en) Targeted thrombosis by tissue factor polypeptides
BG105003A (en) Combinations of protein farnesyltransfer and hmg coa reductase inhibitors and their use to treat cancer
IL128546A0 (en) Cycloalkyl inhibitors of protein farnesyltransferase
AU7525398A (en) Inhibitors for urokinase receptor
CA2293808A1 (en) Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases
AU2821000A (en) Matrix protein compositions for induction of apoptosis
WO2001023522A3 (en) Compositions and methods for p53-mediated repression of gene expression
AU2990300A (en) Deglycosylated kringle 1-5 region fragments of plasminogen and methods of use
MX9703208A (es) Tetra-y pentapeptidos substituidos inhibidores de proteina; farnesil transferasa.
GB9723824D0 (en) Cytostatic agents
ECSP972339A (es) Inhibidores de cicloalquilo de la farnesil transferasa de las proteinas
AU2003200721A1 (en) Compositions and methods for the treatment of tumor